Lee HB, Lee SB, Kim M, Kwon S, et al. Development and validation of a next-generation sequencing-based multigene assay to predict the prognosis of estrogen receptor-positive, HER2-negative breast cancer. Clin Cancer Res 2020 Oct 7. pii: 1078-0432.CCR-20-2107.
PMID: 33028590